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Chapter 1 
 
Executive Summary 
 
Bioinformatics in India started with the launch of the BTISNet1 by the DBT in 1986. The 
DBT itself had been established a earlier in 1986 and the launch of the BTISNet within a 
year, in many ways, legitimised not only DBT’s existence, but also its importance in fulfilling 
India’s (rather Jawaharlal Nehru’s) vision of “scientific” socialism – of science at the service 
of Indian society (Tyabji, 2007). Not surprisingly, DBT’s, and thereby bioinformatics’, goal 
has since been overarchingly developmental, i.e. biotechnology for raising the standard of 
living for India’s poor through job creation, skilled manpower development and 
development of scientific infrastructure.  
 
From its beginning in 1986, the development of informatics and telematics, as bioinformatics 
was called in late 80’s, went beyond its overarching developmental objectives to find 
meaningfulness in the context of “…national security as well as international 
competitiveness” (PCd, 1985: 17.42, 17.52). In the late 80’s, informatics was a tool for 
computerising or modernising existing systems and while the word was frequently used in 
conjunction with biotechnology, it was by no means its only association. Rather, the term 
Informatics appears to have loosely embodied the message of modernisation – to project an 
image of a ‘modern India’ through the use of modern ‘western’ tools in use in the west.  It 
wasn’t until the mid-90s, and after the political turmoil of the early 90’s, that the 
bioinformatics sector begun to take shape.  
 
Tangible policy objectives were identified to help develop the sector  such as 
entrepreneurship development initiatives to attract private sector engagement, setting up 
biotech/bioinformatics infrastructure to facilitate entrepreneurs and attract researchers in 
the field, budgetary allocation earmarked for “bio-infor-matic systems” (PCe, 1992; 18.4.6; 
18.5), etc. At the same time, there was recognition of a lack of indigenous expertise and 
experts.  This resulted  in policies for ‘International Cooperation’ becoming much more 
detailed at the same time policies sought to move away from the nations’ immediate 
geopolitical sphere of influence in favour of academic and industry linkages with R&D 
                                                 
1 Biotechnology Information System (BTIS) network “to create an infrastructure that enables it to 
harness, biotechnology through the application of Bioinformatics” (DBT, nd). 
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centres farther afield  to, primarily, initiate north-south technology transfers (PCe, 1992: 
18.3.42).  
 
By the mid to late 90’s “Genetic engineering units and a network of bio-infor-matic system” 
were among the first 11 “national infrastructure facilities” set up under the DBT (ibid: 
18.5.31). The “International Centre for Genetic Engineering and Biotechnology (ICGEB)2,” 
was created in New Delhi as one of the 3 autonomous research institutes promised by the 8th 
five-year plan. ICGEB, in 1994, became an autonomous centre under the United Nations 
Industrial Development Organization (UNIDO) with India and Italy becoming its largest 
funders; ICGEB’s current membership covers 64 countries, with an additional 21 pending 
ratification. ‘Genome mapping and sequencing’ became a ‘thrust’ area of DBT with the 
stated goal of “strengthening, expansion and operationalisation of a country-wide network in 
bioinformatics” (PCf, 1992: 10.1.35). The Indian Space Research Organisation (ISRO) 
INSAT (Indian Satellite) jointly with Department of Information Technology (DIT), 
Ministry of Communications and Information Technology launched the telemedicine3 
network including telepathology (Mishra et.al, 2009), in 1999 The Sanjay Gandhi 
Postgraduate Institute of Medical (SGPGIMS) Lucknow, a pioneer in telemedicine since 
early 2000’s, currently boasts global linkages and has launched a School of Telemedicine and 
Biomedical Informatics to develop informatics skills. Today, India’s telemedicine network is 
connected via V-SAT to the 53 Heads of State network in the Pan-African e-Network including 
53 hospitals and 53 learning centres; the South Asian Association for Regional Cooperation 
(SAARC) countries telemedicine networks; the Oregon Health and Science University, 
Portland, USA etc (see http://www.sgpgi-telemedicine.org) etc. 
 
Aided by India’s economic liberalisation of the early 90s, the biotechnology sector saw a 
spate of policies that may have provided the early catalyst for the sector’s eventual success. 
However, the extent to which success may have been the result of a lucky mix of global and 
local circumstances instead of home-grown policies is debatable. In any case, the biotech 
policy mix was varied; targeting entrepreneurship development initiatives to attract private 
sector engagement, setting up biotech/bioinformatics infrastructure to facilitate 
entrepreneurs and attract researchers in the field, reversing brain drain to developed 
countries and creating budgetary allocations earmarked for “bio-infor-matic systems” etc 
(PCa, 1992; 18.4.6; 18.5; 18.3.35), etc.  
A vision statement for the biotech sector, the document 'Biotechnology - A Vision - Ten 
Year Perspective’ (Vision hereafter) was presented by Prime Minister Vajpayee on September 
7, 2001. Vision’s intended objective was to manage and boost the unprecedented growth in 
the drugs and pharmaceuticals sector in the preceding years. Vision’s stated vision was 
“attaining new heights in biotechnology research, shaping biotechnology into a premier 
precision tool of the future for creation of wealth and ensuring social justice – especially for 
the welfare of the poor” (DBT, 2001). Genomics and Bioinformatics were ranked as the top 
two biotech areas in the list of focus areas earmarked for public support. A primary target 
                                                 
2 http://www.icgeb.trieste.it/about-the-centre.html 
3 Defined as “remote monitoring of physiological data e.g. temperature and blood pressure that can 
be used by health professionals for diagnosis or disease management. …also covers the use of 
information and communication technology for remote consultation between health professionals or 
between a health professional and a patient e.g. providing health advice by telephone, 
videoconferencing to discuss a diagnosis or capturing and sending images for diagnosis” (Royal 
College of Nursing; see http://www.rcn.org.uk/development/practice/e-health/telehealth_and_telecare). 
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for bioinformatics was building world-class infrastructure “data warehouses, … mirror sites 
to decipher the international data…” and supporting cutting-edge speciality informatics-of-
the-future like neuroinformatics. Another equally important target was in the area of skilled 
manpower acquisition and development (see 10th plan). Efforts to reverse the brain drain to 
developed countries, a policy target from the mid-90s, gained momentum during this time. 
Attracting eminent Indian Diaspora to lead national centres of excellence provided the best 
solution for bridging the indigenous knowledge gap and becoming more self-reliant as a 
nation. At the same time, the Diaspora provided ready linkages to globally renowned 
research institutions without India entering into costly international collaborations with 
developed countries that were increasingly viewed with distrust (a well documented fact) as 
advantaging those countries at India’s expense. 
 
By 2002, the developmental objectives of skilled manpower development and skilled job 
creation began to be subsumed within aspirations of ‘global leadership.’ Bioinformatics was 
chosen as one of the fields that was “expected to be all pervasive and have far-reaching 
impact” in India’s bid to become a global leader (PCg, 2002; 10.159). That India desired to 
be a global leader, “in selected fields” and bioinformatics, was evident,   given the nation’s 
globally successful experience in IT and pharmaceuticals. The proposed bioinformatics 
expansion plans involving substantial public spending commitments are testament to that 
fact.  
 
In-line with this global leadership aspirations for bioinformatics, the basic research in 
bioinformatics and nanotechnologies were earmarked for long-term R&D public funding 
under the funding category of projects that are “uncertain and the gestation period could be 
more than 10 years. …unattractive for private sector funding” (ibid: 10.161). Interestingly, 
“large database” development was earmarked for short-term funding, i.e. projects with 1-3 
year gestation periods, “immediate commercial potential and, therefore, should be funded to 
a large extent by industry with minimum support from the government funds” (ibid). 
International bids to collaborate with India in bioinformatics appears to have been 
quantitatively substantial enough to have allowed India to cherry pick alliances- 
“Cooperation with India has been sought by several countries in this emerging field of 
Bioinformatics in view of the progress made and expertise developed” (BTIS, nd). India’s 
Apex Bioinformatics centre was designated as a referral center for UNDP/FAO/UNIDO’s 
regional agricultural information network/database (FARM programme).  Already, the DBT 
networked with similar centres in China, Indonesia, Philippines, Thailand, Vietnam, Israel, 
Poland, Turkey and Malaysia, while BTISNet, launched in 1986, continued to expand and 
currently covers 65 institutions nationwide, generating 1200+ bioinformatics peer-reviewed 
publications. 
 
MSc/Mtech programs in Bioinformatics were launched. The National Board of 
Accreditation (NBA) of technical education joined the ‘Washington Accord’4 as a provisional 
member to “ensure acceptance of its accreditation procedure amongst the member countries 
of the Accord” (IEA, nd). India hosted The Fifth International Conference on 
Bioinformatics (InCoB 2006) jointly organized by Department of Biotechnology, Govt. of 
India New Delhi, Jawaharlal Nehru University, New Delhi and Indian Institute of 
                                                 
4 Estb 1989; international benchmark for engineering degrees; initial signatories UK, Ireland, 
USA, Canada, Australia, New Zealand (IEA, nd). 
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Technology Delhi, under the aegis of Asia Pacific Bioinformatics Network (APBionet). 400 
scientific presentations are made on seven different Bioinformatics topics.5 The 
Bioinformatics Policy of India (BPI-2004) was presented in 2004. 
 
By 2007-2008, at a time of global growth, India’s ambition of global leadership in biotech, 
which began to take shape in the mid-noughties, became a well documented end-point. 
DBT’s “ultimate objective is to make India globally competitive in the emerging bio-
economy…” (PCh, 2007: Chapter 8.54 (pp177)), while the 11th plan presented in 2008 stated 
that “capabilities in S&T, therefore, are reckoned as a benchmark for establishing the status 
of the development of a nation. India must occupy a frontline position in this listing 
[highlighted in bold for emphasis]. The Eleventh Five Year Plan approach to S&T will 
be guided by this ambition and emphasis will be on” basic research (PCh, 2007: Chapter 
1.3.48 (pp30)). The rhetoric is undeniably nationalistic and ambitious, although, only a 
handful of sectors were chosen to deliver these goals, namely medical bioinformatics and 
nanobiotechnology applications among a few others (PCh, 2007: Chapter 8.55 (pp178)).  At 
the same time, the Department of Information Technology (DIT) was focused on grid 
computing, high performance networking, bio-informatics, nanotechnology and even going 
beyond bioinformatics to the next step “convergence of bio-info-nano technologies and 
cognitive science” (PCh, 2007: Chapter 12.2.25 (pp437)).  
 
The challenges to achieving the global leadership goals were numerous, ranging from 
regulatory and funding deficits to skilled manpower shortages. In response, the policy 
solutions were developed along different strands ranging from innovative funding 
mechanisms and support for public-private partnerships to establishing clusters, rejuvenating 
universities with Bioinformatics courses and certifications, expanding infrastructure in higher 
supercomputing capabilities, biogrid, human resource development and linkages with 
industry.  Additional emerging areas of R&D support were also identified,  such as  
“genomics, proteomics, pharmaco-genomics, and in-silico drug design” (PCh, 2007: Chapter 
8.58 (pp178)). Several bioinformatics research institutions were setup with proposals for 
three autonomous Translational Molecular Medicine Centres” (PCh, 2007: Chapter 8.61 
(pp179)); Advanced Centre for Protein Informatics, Science, Engineering and Technology; 
50 centres training and research institutes in Biotechnology, Bio-informatics, Nano-materials 
and Nanotechnologies etc. (PCh, 2007: Chapter 1.3.47 (pp30)).  
 
DBT launched the ‘National Biotechnology Development Strategy’, in 2007 (NBDS, 2007; 
see comparison table of NBDS 2007 and 2014 at the end of the 12th plan). Within DBT’s 
‘global leadership’ goals, Bioinformatics appears to be everywhere. For instance, the 11th plan’s 
focus areas are (note: this is the 11th plan’s focus areas, not just DBT’s goals and thus they 
are shared by DBT, SCIR, CSIR, DIT etc) “…medical bioinformatics, 
…Nanobiotechnology applications for drug, delivery, biosensors, microbial prospecting for 
novel compounds, genes… “(PCh, 2007: Chapter 8.55 (pp178); for details achieved per plan 
period, please see Chapter 2). However, it must be noted that these proposals for expanding 
the bioinformatics sector are still focused on skilled manpower development/acquistion, 
expanding state-of-the-art infrastructure and funding mechanisms. 
 
                                                 
5 http://www.scfbio-iitd.res.in/seminar/incob.htm 
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In contrast to the exuberance of all things related to bioinformatics in the 11th plan 
(presented in 2008 for the 2007-12 period), the 12th Plan (presented in 2013 for the 2012-17 
period) is muted (rather almost) silent on the subject of bioinformatics. For instance, the 12th 
plan proposes e-governance, e-security, e-learning etc but no e-health. There are proposals 
to expand or launch computerised databases of patient records etc at various levels, tele-
medicine nodes, but little or no involvement with classical bioinformatics. Even the report 
on the 11th plan’s achievements (contained within the 12th plan document) never mentions 
the word informatics or bioinformatics (PCi, 2013: BOX 8.4: (pp 250)).  
 
In contrast to the 2007-2008 period, the biotechnology policy directives in the aftermath of 
the 2008-09 global recession were muted, (almost) silent, on the subject of bioinformatics. 
Policy engagement with bioinformatics appeared to be restricted to proposals expanding or 
launching computerised databases of patient records at various levels, increasing tele-
medicine nodes etc. Notably, the 2011 Report of the Working Group on Biotechnology (RWGoB, 
2011) under the aegis of the DBT, produced a detailed report of gaps, challenges and 
recommendations for developing/expanding the bioinformatics sector without broaching 
the subject of entrepreneurship as either a gap, challenge, or as an area needing policy 
support. The RWGoB was intended as a guiding report for the 12th Five Year plan’s biotech 
strategy although, interestingly, very little of its bioinformatics-related recommendations 
made it to the actual 12th plan document. 
 
Today, after almost 25 years of bioinformatics policy targeting development of skilled 
manpower and acquisition of eminent scientific Diaspora, the sector is dominated by 
eminent academics-scientists with few incentives for exchanging the lab for the factory floor. 
The result is low levels of entrepreneurial activity with few ‘business-minded’ leaders to lead 
commercialisation. As of 2011, there were 200 bioinformatics companies …(needs accurate data from a 
reliable source). In reality, the private sector consists of only a handful of organisations (see 
table 1 below). This bleak scenario is made worse by little or no private sector funding with 
private investors, VC’s stymied by regulatory uncertainties (which regulations apply – are 
regulations IT oriented or biotechnology based?), uncertain scientific outcomes and skilled 
manpower shortages. For instance, the Burrill Report (2014: 16) notes, 
 “there is, however, an urgent need for regulation of bioinformatics as regards the 
 safe and ethical use of personalized data on platforms accessible by multiple parties 
 or even the public at large. The absence of a regulatory framework to control and 
 monitor the access to genomic data can compromise use of the information and 
 serve as a drag on the growth of the sector.”  
The bottom line being that the GoI remains the primary funder (with a handful of 
exceptions) in bioinformatics. In summary, this preliminary study suggests considerable 
barriers to enter India’s bioinformatics sector and further research would be helpful in 
revealing the factors underpinning the lack of entrepreneurial activity. 
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Notably, and in contrast to the above conclusion, industry reports predict a promising 
future, at the same time acknowledging the current low levels of entrepreneurial activity in 
the sector. For instance, in 2012 the Federation of Indian Chambers of Commerce and 
Industry (FICCI – a GoI organisation) predicted that “In 2011-12 the sector recorded a 
growth of 9.6 percent clocking Rs 265.7 crore in 2011-12 …the continual  increment  in  the  
healthcare  expenditure amongst Indians is fuelling growth in the market” while 
acknowledging that the “Indian bioinformatics market, which is the smallest of biotech 
industry segments constituting barely 2% of the market share in overall revenue” (FICCI, 
2012). Similarly, Chakrabarty and Agooramoorthy (2010: 3) noted,  
 “The bioinformatics industry is rapidly expanding around the IT service centres. As a 
 result, companies based in south India where the IT hub is located (Bangalore, 
 Hyderabad and Chennai) vis-a-vis few companies in the north India. The south 
 Indian key players are Infosys Life Science, GVK Biosciences, Jalaja Technologies, 
 Kshema Technologies, IBM India, Strand Genomics, and TCS. In New Delhi, 
 companies such as HCL Life Science, Mascon Life Science, Labvantage Solutions, 
 SAS India, and Life Sciences Technologies are performing well.”  
While Burrill Report (2014: 8) concluded that “Though bioinformatics represents the 
smallest of India’s biotechnology sectors having generated just a little more than 1 percent of 
the industry’s revenues in fiscal 2013, it is an area of growing importance and opportunity.” 
According to the Federation if Indian Chambers of Commerce and Industry (FICCI – a GoI 
organisation; FICCI, 2012: 10) report on BioInformatics: 
  
“In 2011-12, the sector recorded a growth of seven percent clocking. …The sector had 
witnessed an increase in the domestic revenue during last year. This rise was attributed to 
factors such as an increase in public funding towards research and development (R&D) from 
the Government of India, decline in costs of human genome sequencing, increase in R&D 
investments by companies, and an increase in the number of orders for contract research 
activities. The sector recorded a growth of 9.6 percent clocking Rs 265.7crore in 2011-12.  
 
The Indian bioinformatics market, which is the smallest of biotech industry segments 
constituting barely 2% of the market share in overall revenue, grew by 11.5% in FY 2010-11 
to reach US$ 58 Million. Tata Consultancy Services (TCS) and Council of Scientific and 
Industrial Research (CSIR) have launched 'Bio Suite', the country's first comprehensive 
Table 1 
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software for bioinformatics, which caters to the needs of fields such as biology, post-
genomic drug discovery and other related areas. Bio Suite was developed under the New 
Millennium Indian Technology Leadership Initiative programme (NMITLI). Indian 
bioinformatics market is focused on biological database creation and management; data 
analysis and visualisation tools; and services and IT infrastructure. Companies from IT and 
life science sectors are gradually gaining traction in the bioinformatics industry by developing 
innovative products and services. Rising R&D activities coupled with the favourable 
government activities is primarily driving the market. Further, the continual increment in the 
healthcare expenditure amongst Indians is fuelling growth in the market.”  
 
 
Biospectrum-ABLE, 2012 in FICCI, 2012.  
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Chapter 2 
 
Details by Plan Period 
 
Seventh Plan (1985-90)  
 
Before 1985 
The Government of India’s (GoI’s) efforts to create a separate institution for managing 
India’s foray into biotechnology led to the creation of the National Bio-Technology Board 
(NBTB) under the Department of Science and Technology (DST) in 1982. The NBTB was 
“inter-ministerial” (i.e. not yet a separate department or interdepartmental) with a mandate 
of using biotechnology for fulfilling national developmental objectives in “agriculture, 
medicine and industry” (PCc, 1985). Several large-scale projects were proposed as part of the 
Sixth Five Year Plan, but failed to take off (Ramani and Guennif, 2014: 195).  
 
1985-90 
The Department of Biotechnology (DBT) was created in 1986 to replace the NBTB. 
However, there is no mention of a separate biotechnology policy or biotechnology 
department until the 8th Plan in 1990. The 7th plan’s S&T policy emphasis was on “skilled 
manpower” as below,  
i) creating opportunities for skilled-job creation,  
ii) developing the ‘technological’ skills of the Indian labour force in line with the 
latest and promising future technologies, 
iii) reversing brain drain and appointing eminent “scientists and technologist” to 
run the newly created institutions (see Quote 2; PCd, 1985: 17.45, 17.48, 
17.56) through “lecture assignments, consultancy in industry and assistance 
in setting up pilot projects in India” (17.141). 
Under the Seventh Five Year Plan, development of Biotechnology projects were listed as an 
objective under ‘Industry Perspective’ (with the public sector acting as a “pace-setter” for 
boosting emerging technologies) and  ‘Agricultural perspective’ (linking agri-science and 
industry to increase factor productivity).  
For the first time, we find mention of the word informatics in India’s S&T policy as a “new 
developing area” earmarked for public support focus and “…relevant to national 
development, but very important from the viewpoint of national security as well as 
international competitiveness” (PCd, 1985: 17.42, 17.52). Notably, informatics and telematics 
were ranked second among the 11 focus areas identified (ibid). Similar to the national 
biotechnology policy, focusing public support on the development of a ‘technologically’ 
skilled labour force became the primary strategic objective for developing India’s informatics 
capabilities; it helped fill the “…need to weld the new field of informatics to the educational 
system (ibid, 17.91 (quote) and 17.114). ‘Skilled manpower’ was expected to link science to 
industry and bring the fruits of science to the Indian population i.e. fulfil developmental 
goals, empower the weak and other similar social objectives (PCd, 1985: 17.45).  
 
The  7th Plan also promised to develop the “information base” by setting up a National 
Science and Technology Information System that would cover “both bibliographic and 
technical information required for scientific work, as well as an integrated data-base for 
decision-making and policy formulation in the field of S and T” (ibid, 17.115). The National 
Science and Technology Information System was to be  created jointly by the Department of 
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Electronics, Dept of Science and Technology (DST), Council for Scientific and Industrial 
Research (CSIR), Department of Environment, Defence Research and Development 
Organisation (DRDO), Indian Council of Agricultural Research (ICAR), Indian Council of 
Medical Research (ICMR), Controller General of Patents, DGTD etc. Towards this end, 
policies encouraging R&D spending by industry were noted, ranging from manpower 
development to partnerships with research institutions etc. 
 
However, a word of caution that while informatics was considered a ‘thrust area’ for S&T 
policy; its understanding was much broader than simply bio-informatics. For instance, the 7th 
Plan notes that informatics was to be a tool in office management “Office management should 
be modernised by the replacement of conventional methods with modern equipment. The 
capabilities that are available through recent developments in informatics should be fully 
assimilated” (17.147). Thus, Informatics was a tool for computerising or modernising existing 
systems and while the word was frequently used in conjunction with biotechnology – it was 
by no means its only association. 
 
“India was the first country in the world to establish, in 1987, a Biotechnology Information 
System (BTIS) network to create an infrastructure that enables it to harness biotechnology 
through the application of Bioinformatics” (DBT, nd). Today, it is an extensive nationwide 
network connecting 120 institutions (under the DST, CSIR, ICMR, ICAR, Universities and 
Institutes under Human Resource Ministry). BTISNet aims to develop bioinformaticians and 
bioinformatics research. According to DBT (nd) BTISNet researchers have published 1000+ 
peer reviewed bioinformatics papers in the last five years and 3000+ papers in other areas of 
biotechnology  that has led to entrepreneurial spin-offs e.g. Biosuite of Tata Consultancy 
Services (TCS) or software packages for visualisation of bioinformatics data by Strand 
Genomics. BioGrid India – a high bandwith nationwide Virtual Public Network (VPN) for 
linking BTISNet institutions (discussed later in the 12th Plan), is also a BTISnet spin-off.  
 
 
1990-97 (Eighth Five Year Plan 1992-97) 
Target Growth: 5.0%  
Actual Growth: 6.01% 
The focus remains the same as the Seventh Plan period although the policy approach 
becomes more detailed based on experiences (i.e. mostly failure to meet 7th Plan targets). For 
instance, “Entrepreneurship Development Cells in all science/engineering/IITs and other 
academic institutions by the concerned Central/State agencies” were proposed to reverse 
brain drain, and encouraging the ‘entrepreneurial’ spirit started to become a policy goal. Six 
Science and Technology Entrepreneurship Parks (STEPs) were created. (PCe, 1992: 18.4.8). 
‘International Cooperation’ became a much more prominent vehicle for achieving the 
national ‘employment’ based goals of the 7th Plan. For instance, there was a move to identify 
and drop the less productive relationships (which so far had been based in India’s immediate 
geographic region) in favour of industry linkages with R&D centres abroad, primarily with 
north-south technology transfer goals (PCe, 1992: 18.3.42). The National Register of Foreign 
Collaborations (NRFC) (18.4.10) and the Interface for NRI scientists and Technologists 
(INRIST) were established. (18.5.21). 
 
Most importantly the  8th Plan mentioned “bio-infor-matic system” for the first time under 
the separate heading of Biotechnology (PCe, 1992; 18.4.6; 18.5). This was in-line with the 
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establishment of a separate Department of Biotechnology (DBT) in 1986 with the stated 
goal of “…development of specialized manpower and infrastructure …and a very strong 
base of R and D” (18.5.6). Bioinformatics was identified as one of the tools for meeting 
DBT’s goals,  in-line with the national S&T’s policy’s developmental goals of increasing i) 
skilled labour, ii) employment with a focus on skilled employment, iii) using science for 
raising living standards and  the weakest sections of society. For the first time, informatics, 
one of the three “emerging domains of high technology,” was named in the biotechnology 
budget outlay (18.5.31).   
 
“Genetic engineering units and a network of bio-infor-matic system” were among the first 
11 “national infrastructure facilities” established under the newly created DBT (ibid). 
Biotech departments were created in 26 universities and the “Biotechnology Consortium 
India Limited (BCIL) a bioventure company” was created “in collaboration with industry 
and financial institutions with a view to facilitating commercialisation of biotechnology in 
India” (ibid).  
  
1997-2002 (Ninth Five Year Plan 1997-2002)  
Target Growth: 6.5%  
Actual Growth: 5.35% 
“S and T Policy and Approach during the Ninth Plan 
 -Need for mounting efforts to control population and improve the levels of food security, economic 
 growth, literacy, health and so on, apart from realising the technological strengths in the emerging 
 global industrial/economic environment by optimal utilisation of the S and T Systems in India. 
 -Scientists with exceptional capabilities should be nurtured and supported fully by offering them, 
 with in the country facilities comparable with international standards. 
 -To be in the forefront in some of the chosen fields, the research programmes should be taken up on a 
 mission mode through appropriate re-structuring and re-orientation.” (PCf, 1997) 
 
DBT’s goals remained the same as in the previous plan period. The only change was a new 
focus on the national directive to all S&T departments to “make a mark in the light of the 
international control regimes pertaining to IPR and TRIPS for protecting the interest of the 
country” (ibid) and a necessity for “India to emerge as global R and D platform” (ibid, 
10.15). The new policy direction was based on a growing (and documented) distrust of 
partnership arrangements with developed countries that advantage those countries at India’s 
expense. The focus was thus on technological self-reliance, control over IPR (and related 
organisations like WTO etc), building local innovation capacity and R&D collaborations 
with global research institutions.  
 
‘Genome mapping and sequencing’ was selected as a ‘thrust’ area of DBT with a goal of 
“strengthening, expansion and operationalisation of a country-wide network in 
bioinformatics” (PCf, 1992: 10.1.35).  
 
The “International Centre for Genetic Engineering and Biotechnology (ICGEB)6,” was 
established in New Delhi as one of the 3 autonomous research institutes promised by the 8th 
five-year plan. In 1994, ICGEB became an autonomous centre under the United Nations 
Industrial Development Organization (UNIDO) with India and Italy becoming its largest 
                                                 
6 http://www.icgeb.trieste.it/about-the-centre.html 
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funders; ICGEB’s current membership covers 64 countries, with an additional 21 pending 
ratification. 
 
Telemedicine7 including telepathology (online sharing of patient pathology reports/images 
between members) network was launched in 1999 by Indian Space Research Organisation’s 
(ISRO) INSAT (Indian Satellite) jointly with Department of Information Technology (DIT), 
Ministry of Communications and Information Technology (Mishra et.al, 2009) e.g. the 
National Rural Telemedicine Network etc. According to the ISRO 2012-13 report, 311 rural 
hospitals were networked with 80 superspeciality hospitals located in the major metros and 
18 mobile vans (ibid). The Sanjay Gandhi Postgraduate Institute of Medical (SGPGIMS) 
Lucknow, a pioneer in telemedicine since the early 2000s, currently boasts global linkages 
and has launched a School of Telemedicine and Biomedical Informatics to develop 
informatics skills. Today, India’s telemedicine network is connected via V-SAT to the 53 
Heads of State network in the Pan-African e-Network covering 53 hospitals and 53 learning 
centers; the South Asian Association for Regional Cooperation (SAARC) countries 
Telemedicine networks; the Oregon Health and Science University, Portland, USA etc (see 
http://www.sgpgi-telemedicine.org). The success of telemedicine and its rapid take-up has 
encouraged private sector participation. Private firms from mobile companies (BPL Mobile 
in Maharashtra) to private hospital chains (Apollo Hospitals, Fortis Hospitals, Escorts Heart 
Institute and Research etc) have made considerable investments (Mishra et.al, 2009). So 
much so, that the DIT issued a “Recommended Guidelines & Standards for Practice of 
Telemedicine in India” and “The framework for Information Technology Infrastructure for 
Health (ITIH)”in an effort to regulate and standardise telemedicine practices. In 2005, the 
Ministry of Health and Family Welfare created the National Task Force on Telemedicine 
(ibid). ISRO’s proposed HEALTHSAT, a dedicated health satellite, has been in the works 
since 2004 with plans to expand existing networks nationally and globally.  
 
On September 7, 2001, Prime Minister Vajpayee presented the 'Biotechnology - A Vision - 
Ten Year Perspective' (Vision hereafter)– guiding document for the DBT for the 2001-2010 
period. The vision 'Attaining new heights in biotechnology research, shaping biotechnology 
into a premier precision tool of the future for creation of wealth and ensuring social justice – 
specially for the welfare of the poor' (DBT, 2001). In its list of focus areas earmarked for 
public support, Vision ranked basic research in Genomics and Bioinformatics as the first two 
biotech areas. The Genomics development plan was inwardly focused on mapping the 
diseases and disorders afflicting the Indian population as well as the 
animals/organisms/plants/crops important to India (ibid). The Bioinformatics development 
plan targeted two goals. One goal was inwardly focused on increasing basic research capacity 
in bioinformatics along the lines of the inward-looking genomics development plan i.e. using 
bioinformatics capacity to benefit the Indian populace. The other goal targeted developing 
India’s national advantage in the global market, 
                                                 
7 Defined as “remote monitoring of physiological data e.g. temperature and blood pressure that can 
be used by health professionals for diagnosis or disease management. …also covers the use of 
information and communication technology for remote consultation between health professionals or 
between a health professional and a patient e.g. providing health advice by telephone, 
videoconferencing to discuss a diagnosis or capturing and sending images for diagnosis” (Royal 
College of Nursing; see http://www.rcn.org.uk/development/practice/e-health/telehealth_and_telecare). 
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i) by building world-class infrastructure “data warehouses, … mirror sites to 
decipher the international data…” e.g. “GDB, Protein Data Bank (PDB), 
Plant Genome Data Banks, Databases of European Bioinformatics institute 
(EBI)” and supporting cutting-edge speciality informatics-of-the-future like 
neuroinformatics, and,  
ii) by developing a home-grown talent-pool of qualified bioinformaticians to fill 
(inter)national manpower shortages in the field with plans to train “at least 
200 personnel per year to have a core group of 1000 trained experts in five 
years … and 15000-20000 in ten years” (ibid).  
 
The policy trend away from self-reliance and or developmental goals towards “international 
competitiveness” or ‘global leadership’ aspirations in select areas of biotechnology was 
evident, although muted. For instance, e.g. the plan proposed to “make the country a major 
power in matters relating to IPR in biotechnology.” 
 
 
2002-07 (Tenth Five Year Plan 2002-07)  
Target Growth: 8%  
Actual Growth: 7.7% (8.9% in the last 4 years). 
The policy focus was still on skilled manpower and skilled job creation. There was a strong 
focus on bio-informatics and health-informatics with the NICNET8 being refocused as a 
nationwide medical database and health information reporting network for the medical and 
research community with the aim of bringing medical colleges within its network. Emphasis 
was also laid on talent-development from pre-college levels and using attractive funding 
incentives, incubators, laboratory spaces, internationally renowned faculty to reverse brain 
drain.  
 
At the same time, there was an emphasis, rather urgency, to build state-of-the-art world class 
research facilities to i) attract Diaspora renowned in the field and keep young talent within 
India, while ii) progressing rapidly from self-reliance and increasing national advantage to 
capturing global market share. Towards this end,  
 “…a national facility for virus diagnosis and quality control of plants raised by tissue 
 culture;  programme on genomics, … fourteen genetic clinics …for providing 
 molecular diagnosis and counselling for the common genetic disorders prevalent in 
                                                 
8 The National Informatics Centre (NICNet) was established in the 70’s, initially with UNDP 
funding, and later by GoI. It was to link government departments at different levels, transfer benefits 
to the rural and weaker sections of society, map indigenous plant genomes etc. In the 90’s NICNet 
was proposed for Management Information Systems (MIS) but it “failed to take off” by GoI’s own 
admission in the 10th plan (PCg, 2002: 2.2.27). NICNet is now a satellite-based electronic network 
with 3 state-of-the-art National Data Centres (NDCs) in NDelhi, Pune, Hyderabad and 31 small DCs 
in state capital connecting 1200+ nodes. An ICMR-NIC joint initiative provides bio-medical and 
health information to the research and medical community including updates on diseases and health 
risks relevant to India. It is the designated IMC - Indian MEDLAR Centre (Medical Literature 
Analysis and Retrieval System (MEDLARS) of the National Library of Medicine (NLM) is one of the 
world’s largest medical bibliographical databases, consisting of millions of medical reference in each 
database through V-SAT) (Mohan, 2002: 372).  
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 the country. …powerful computational capability for handling large-scale human 
 genome sequence data for functional genomics programme, robotic methodologies 
 for genotyping and Polymerase Chain Reaction (PCR) based diagnostics for 
 common genetic disorders, …mirror sites for genomics, 38 post-graduate, post-
 doctoral and one-year diploma courses, 19 additional courses and 5 Centres of 
 Excellence  in bioinformatics” are launched (PCg, 2002; 10.43; 10.47; 10.48). The 
 problem is that churning out bioinformatician is difficult in reality. The subject of 
 Bioinformatics requires expertise in two disparate fields, bioscience and IT. This 
 implies studying two different subjects simultaneously however since  pay scales of
 bioinformaticians are less than that of an IT or biosciences professional, the financial 
 or time investment for qualifying in bioinformatics is ill-justified (Biostars, 2014; 
 Levine 2014: 1304; Dr Kristina Obom in Langer, 2008: 21). For instance, since 
 the DBT started the yearly Bioinformatics National Certification (BINC) 
 examination in 2005 (http://bioinfo.ernet.in/) only 140 students have qualified in 
 the nine times it has been conducted between 2005-2013 (Guptal et.al, 2014). 
 
Proposed plans focused on expanding the BTISNet (see 7th plan) to launch BioGrid India, 
 “setting up of teraflop supercomputer facilities for bioinformatics; establishment of a 
 National Bioinformatics Institute for carrying out various activities like policy 
 making; establishment of a Centre for Genome Informatics for carrying out research 
 related to genomics and proteomics that include database mining, computational 
 gene discovery, sequence similarity searching, gene expression analysis” (ibid:10.114). 
 Currently 100 databases are available on BTISNet including “mirror sites of 
 internationally recognized genomic databases such as GDB, Protein Data Bank 
 (PDB), Plant Genome Data Banks, Databases of European Bioinformatics institute 
 (EBI) and public domain bioinformatics software packages are also available on the 
 BIOGRID” for indigenous “unhindered mining of high quality data from well 
 established primary and secondary information sources” (BTIS, nd).  
 
In terms of policy direction, at the time of writing the 10th plan, bioinformatics had 
graduated from being an emerging field that could fulfil national developmental goals (see 
7th, 8th and 9th plan) to a field that was “expected to be all pervasive and have far-reaching 
impact” where “it has become imperative for India to develop technologies, products and 
services of international cost and quality and become a global leader at least in some selected 
fields. Pursuing purposeful R&D is the only way to meet this challenge” (ibid: 10.159). Yet, 
there was a sense of wariness, a fear of losing the national ‘edge’ by trying to achieve too 
much too soon as the plan cautions against complacence and failure - “however, we have to 
be careful not to fritter away our scarce financial and human resources by trying to tackle all 
the areas” (ibid). The desire for global leadership is evident, but only “in selected fields” and 
bioinformatics, given the nation’s globally successful experience in IT and pharmaceuticals, 
was a natural choice and the proposed bioinformatics expansion plans involving substantial 
public spending commitments bear testament to that fact.   
 
In-line with this policy direction, the 10th plan identified basic research in bioinformatics and 
nanotechnologies as sectors “which are expected to be all pervasive and have far-reaching 
impact” with earmarks for long-term R&D funding. According to the Working Group on IT 
for the 10th 5-yr plan, long-term funding was assessed for projects that were considered 
“uncertain and the gestation period could be more than 10 years. Such technologies may be 
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unattractive for private sector funding and therefore, long term R&D will have to be funded 
by the government” (ibid: 10.161). Thus, funding for bioinformatics including telemedicine 
R&D in the 10th plan was almost entirely publicly supported as they were yet to be 
considered attractive for funding by the private sector, VCs, or FDI sources. Interestingly, 
“large database” development was earmarked for short-term funding, i.e. projects with 1-3 
year gestation periods, “immediate commercial potential and, therefore, should be funded to 
a large extent by industry with minimum support from the government funds” (ibid).  
 
Furthermore, the 10th plan proposed “international cooperation” only for long and medium-
term projects, but not for the short term ones and, appeared to be in a position to cherry 
pick the institution or country with whom to collaborate. For instance, the 10th plan noted 
that “India should seek international cooperation in these areas, based on the strength of 
cooperating countries, institutions, research labs or industries” (ibid) while the 
bioinformatics strategy noted that “Cooperation with India has been sought by several 
countries in this emerging field of Bioinformatics in view of the progress made and expertise 
developed” (BTIS, nd). At the time of writing the 10th plan, India’s Apex Bioinformatics 
centre was also the designated referral centre for UNDP/FAO/UNIDO’s regional 
agricultural information network/database (FARM programme); the DBT had already been 
networked with similar centres in China, Indonesia, Philippines, Thailand, Vietnam, Israel, 
Poland, Turkey and Malaysia. 
 
Achievements of the 10th plan period (as laid out on 19/12/2007 at the presentation of the 
11th plan), 
 
- 1985-86: started MSc/MTech programs in 5 Universities, now 63 (22 programs 
added in 2002-07). Including MSc/MTech/PhD in Bioinformatics. 
- 35 biotech facilities; 1 biotech park at Lucknow, Uttar Pradesh; 5 biotech incubation 
centres at (Hyderabad, Bangalore, Kochi, Chandigarh, Solan).  
- Nationwide BTISNet covering 65 institutions with 1200+ bioinformatics peer-
reviewed publications and 3500 biology/biotechnology research papers published. 
- DBT launched Small Business Innovation Research Initiative (SBIRI) with funding 
managed by the Biotech Consortia India Ltd. (BCIL; a Special Purpose Vehicle (SPV) fund 
manager); by 19/12/2007 (i.e. at the time of presentation of the 11th plan) 10 such 
PPP proposals had been recommended for support. 
- Successfully decoding genome of rice chromosome 11.  
- India hosted The Fifth International Conference on Bioinformatics (InCoB 2006) 
jointly organised by Department of Biotechnology, Govt. of India New Delhi, 
Jawaharlal Nehru University, New Delhi and Indian Institute of Technology Delhi, 
under the aegis of Asia Pacific Bioinformatics Network (APBionet). 400 scientific 
presentations are made on seven different Bioinformatics topics.9 
- Drugs and Pharmaceuticals Sector de-licensed in 23 September 2005 (FIPB, nd) in a 
move to decrease bureaucratic red tape to soften the adverse impact on the 
pharmaceutical reverse engineering industry following a change in TRIPS/patent-
regime in Jan 2005. Patents for drugs were amended on 22 March 2005 to meet 
WTO demand for a product patent regime. However, India managed to negotiate 
the inclusion of a clause for ‘compulsory licensing’ controlling high-costs of ‘life-
                                                 
9 http://www.scfbio-iitd.res.in/seminar/incob.htm 
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saving drugs’ (in 2013 Novartis lost under this clause). Before March 2005, India’s 
patent law 1970 only required patents for ‘process’ and pharma/drug manufacturers 
could copy drugs and sell them in India and other countries with similar regulatory 
environments.  
- National Board of Accreditation (NBA) of technical education joined the 
‘Washington Accord’10 as a provisional member to “ensure acceptance of its 
accreditation procedure amongst the member countries of the Accord” (IEA, nd). 
As of 13 June 2014 the NBA has become a full member, although, only those NBA 
accredited courses in NBA accredited Tier 1 institutions are recognised by other 
signatories (ibid). 
 
2007-2012 (Eleventh Five Year Plan 2007-2012)  
Target Growth: 9% (10% towards the end) 
Actual Growth: 8% 
The biotechnology research objectives were included under the chapter “Innovation and 
Technology” with four “major deliverables”- “Human Resource Development—
Biotechnologists with expertise in Genomics, Proteomics and Metabolomics, Development 
of ‘Info-bio’ and ‘Info-bio-nano’ manpower” (PCh, 2007: Annexure 8.2 (pp190) 
 
The guiding rationale for the DBT was still developmental (i.e. biotech to raise the quality of 
life for the poor, inclusive growth through employment opportunities etc). However, DBT’s 
 “ultimate objective is to make India globally competitive in the emerging bio-
 economy by converting the country’s diverse biological resources to useful products 
 and processes. Developing a strong biotechnology industry and technology diffusion 
 capacity is critical for fulfilling this objective.” 
India’s ambition of global leadership in biotech, which had begun to take shape in the 10th 
plan, became a stated end-point in the 11th plan (PCh, 2007: Chapter 8.54 (pp177)).  
The ‘National Biotechnology Development Strategy’ in 2007(NBDS, 2007) was launched. 
 
 
 
 
 
 
 
 
 
 
 
 
 
To achieve ‘global leadership’ goals the 11th plan’s focus areas were (note: this is the 11th 
plan’s focus areas, not just DBT’s goals and thus they are shared by DBT, SCIR, CSIR, DIT 
etc),  
 “The priority areas for the Eleventh Five Year Plan Focus …diagnostics, implants, 
                                                 
10 Estb 1989; international benchmark for engineering degrees; initial signatories UK, 
Ireland, USA, Canada, Australia, New Zealand (IEA, nd). 
“Capabilities in S&T, therefore, are reckoned as a benchmark for establishing the status 
of the development of a nation. India must occupy a frontline position in this 
listing. The Eleventh Five Year Plan approach to S&T will be guided by this ambition 
and emphasis will be on” (PCh, 2007: Chapter 1.3.48 (pp30)): 
• cross pollinating all S&T departments for basic research. 
• hi-tech ‘manpower' development and better S&T infrastructure.  
• International linkages and membership/participant-status in global S&T projects. 
The deficits identified are, 
“relatively low investment in R&D by the corporate sector, and the lack of synergy 
among R&D institutions and universities. The present output of about 450 doctorates 
per annum in Engineering and Technology”(PCh, 2007: Chapter 1.3.48 (pp30)). 
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 devices, medical bioinformatics, clinical research, stem cell research and regenerated 
 medicine. Nanobiotechnology applications for drug, delivery, biosensors, microbial 
 prospecting for novel compounds, genes, bioenergy and bio-fuels, bioremediation, 
 and so on …International cooperation activities matching national needs and the 
 above priorities, will also be accelerated” (PCh, 2007: Chapter 8.55 (pp178)).  
 
For the DIT, the goal was to strengthen R&D (by strengthening infrastructure and 
manpower skilled in IT) and focus areas included grid computing, high performance 
networking, bio-informatics and nanotechnology (PCh, 2007: Chapter 12.2.24 (pp437)). DIT 
went beyond bioinformatics to the next step “convergence of bio-info-nano technologies 
and cognitive science” (PCh, 2007: Chapter 12.2.25 (pp437)). 
 
The challenges to achieving this global ambition as identified by the 11th plan were,  
-“…creation of investment capital,  
- technology transfer and technology absorption,  
- patentability and intellectual property,  
- affordability in pricing,  
- regulatory issues and public confidence and  
- tailor-made human resources related to all these aspects.” (ibid) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The 11th plan’s proposals were focused on the ‘thrust’ areas identified earlier. 
“Interdisciplinary ‘grand challenge’ projects would be taken up in areas of national 
importance, where biotechnology interventions can bring about significant value addition, 
cost effectiveness and competitiveness in product and process development. These would be 
implemented through special management, administrative and organizational structures for 
time-bound results. Some of the areas identified for this purpose include: …(v) diagnostics 
for health care; …(vii) stem cell biology and regenerative medicine; and (viii) bioengineering 
for implants and medical devices” (PCh, 2007: Chapter 8.59 (pp178)).  
 
For instance (below are the goals of BOX 1 in greater detail),  
- Proposals to strengthen R&D focus (see BOX 1 above) on “Strengthening bioinformatics 
R&D and infrastructure in terms of higher supercomputing capabilities, expansion of 
biogrid, human resource development, linkages with industry, institutional mechanisms for 
software development and validation, development of an Indian portal site and 
BOX 1 
Likewise DBT proposals to overcome these challenges were, 
-“…human resource development” incl. “smarter re-entry for our scientists abroad,  
- new and varied models of creating an innovation-friendly environment,  
- R&D in small and medium size companies,  
- newer ways of collaborating with large companies,  
- establishing centres of excellence and translational research centres,  
- remodelling life science departments in universities/institutions,  
- establishment of technology management centres,  
- promoting dynamic biotech regional clusters,  
- establishment of biotechnology parks and incubators,  
- and setting up of biotechnology regulatory mechanisms” (PCh, 2007: Chapter 
8.54 (pp177-178)). 
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bioinformatics parks and clusters through PPPs, would also be taken up.” (PCh, 2007: 
Chapter 8.57 (pp178)).  
“ …Some of the other important R&D areas would be genomics, proteomics, pharmaco-
genomics, and in-silico drug design” (PCh, 2007: Chapter 8.58 (pp178)).  
 
-Proposals to increase “R&D in small and medium size companies, newer ways of 
collaborating with large companies” (see BOX 1 above) sees the launch of 2 new schemes: 
Biotechnology Industry Partnership Programme (BIPP; PPP for those with ‘breakthrough’ 
potential) and Biotechnology Industry Research Assistance Council (BIRAC; R&D in 
SMEs), expansion of the 10th Plan’s SIBRI.  
 
- Proposals “establishing centres of excellence and translational research centres, remodelling 
life science departments in universities/institutions” (see BOX 1 above) “…focus on 
translational and innovation activities, the existing autonomous institutions would be 
remodelled. This would require expansion of the scope of the institutions by building centres 
of translation, innovations and services along with focused networking. …The Centre for 
DNA Fingerprinting and Diagnostics, Hyderabad, will undertake new activities such as a 
national facility for training in DNA profiling; …creation of a national DNA database. The 
National Brain Research Centre, Manesar, will take up Neural Stem Cell research and set up 
a Clinical Research Centre for brain disorders and Brain Machine Interface. The Institute of 
Life Sciences, Bhubaneswar, will undertake translational activities for the development of 
DNA chip-based diagnostics and nano-medicine.” (PCh, 2007: Chapter 8.60 (pp178-179)).  
 
New Institutions “include institutes for translational research in health science and 
technology; stem cell research and regenerative medicine; UNESCO regional centre for 
science, education and innovation; …molecular medicine and medical genetics. …three 
autonomous Translational Molecular Medicine Centres” (PCh, 2007: Chapter 8.61 (pp179)); 
Advanced Centre for Protein Informatics, Science, Engineering and Technology; 50 centres 
training and research institutes in Biotechnology, Bio-informatics, Nano-materials and 
Nanotechnologies etc. (PCh, 2007: Chapter 1.3.47 (pp30)).  
“The national mission on nano science and technology would be a major new programme, 
designed to enable India to become a significant player in the global race by tapping the 
potential applications of nano science and technology … would focus on basic research, 
infrastructure development for quality nano science and technology research, human 
resource development, forging international collaborations and most importantly, promoting 
PPP in the area of nano science and technology” (PCh, 2007: Chapter 8.69 (pp182)). 
 
-Proposals for “promoting dynamic biotech regional clusters, establishment of 
biotechnology parks and incubators” (see BOX 1). One is a proposed knowledge park,  
“Mohali Knowledge City—Advantages of Clustering ...to build a knowledge city in Mohali, 
Punjab with a vision to promote innovation and startup companies. The cluster includes, on 
a single campus, the Indian Institute of Science Education and Research (IISER), National 
Agri-food Biotechnology Institute, Nanotechnology Institute, Management School, 
Technology and IP Management Centre, Business Centre, an Informatics Centre, 
Centralized Platform, Technology facility, a Good Manufacturing Practices (GMP) 
compliant Bio process Facility for Food and Nutriceuticals, a Technology Park for start-ups, 
and a host of other shared facilities.” (PCh, 2007: Box 1.3.3 (pp30)). 
 
-Proposals “setting up of biotechnology regulatory mechanisms” (see BOX 1) aims to setup 
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a single window clearance for all biotechnology products- the proposed ‘National 
Biotechnology Regulatory Authority’ (PCh, 2007: pp178-180)) 
 
‘Actual’ achievements of the 11th plan,  
- As of 2013 the BTISNet (launched in 1987) has 168 nodes/centers. 
- 5 Centre of Excellences11 (CoEs; Bose Instt., IISc., JNU, MKU, Uni. Of Pune, SCF-
IIT). For instance, bioinformatics CoEs currently have eminent scientists from the 
diaspora, in-house trained manpower, state of the art infrastructure with their work 
focused on solving issues relevant to India e.g. IISC, Bangalore is working on 
“development of database from system level modelling and genome profiling of 
MTB; structural bioinformatics analysis and methodologies for genotype- phenotype 
mapping” for tuberculosis. TRC, Chennai is also using “annotation of genomes of 
mycobacteriophages, and developing bioinformatics tools for analysis of database” in 
tuberculosis as are JNU, IOB Bangalore etc. (BTISNet, 2013). 
- 101 Bioinformatics Infrastructure Facilities (BIF)12,  
- 5 MSc/M.Tech/Diploma in Bioinformatics 
- 97 R&D Projects with 10 in Agriculture Biotech, 17 Medical Biotech, 33 Drug 
designing, 11 Tools for protein and Structural Biology, 9 Tools for genome sequence 
analysis and 10 more planned (BTISNet, 2013). 
- North Eastern Bioinformatics Network (NEBInet) connects 29 institutions and is 
aimed at strengthening R&D in the far off northeast (ibid).    
 
                                                 
11 Databases developed by CoE and others (BTISNet, 2013),   
 “• For protein structure analysis – Bose Inst. (ProFace, InteGeom, ConfPlot, ContPlot)  
 • For structural bioinformatics – IISc, Bangalore (CSSP, MIPS, FAIR, SSMBS)  
 • Genome comparison tools for TB strain identification – JNU, New Delhi  
 • Database for viruses – Pune, Univ. (Viral protein Str., Viral genome resource, Antigen antibody interaction) 
• Buffalo Genome Information Resource (NDRI, Karnal & IASRI, New Delhi)  
• Genomic resource and knowledge base of plant parasitic nematodes of wheat & rice (IARI, New Delhi)  
• Discovery, annotation, validation & characterization of SNPs in Wheat using NGS data  (BTIS, Ranchi & 
CCSU, Meerut).”  
12 In 2006-07 DBT launched the BIF for Biology Teaching through Bioinformatics (BTBI) “The goal of this 
scheme is to expose teachers and students to real-world of science and the use of bioinformatics (Cyber 
bioscience) in solving hard core biological problems.   
 
Source: ABLE-Biospectrum, 2013: 28. 
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                 Source: ABLE-Biospectrum, 2013: 22. 
 
 
    Source: ibid: 29. 
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A large number of institutions offering training/courses in Bioinformatics mushroomed 
during the IT boom years 1997-2002ish but shut down due to credibility and legitimacy 
deficits. Today, according to BioSpecturm only a handful of the GoI funded institutions are 
trusted by employers.  
 
Achievements of the 11th plan (according to Report of the Working Group on Biotech 
(RWGoB, 2011): 12% of the budget was spend in “International 
collaboration/bioinformatics and HRD” (RWGoB, 2011: 2); 137 projects were funded in 
Bioinformatics among which 57 projects generated 50 publications with impact factor >7 
(ibid: 19); 25 databases were launched (ibid: 19); 25 open domain use software were created 
(ibid: 19); 200 software packages (ibid: 29); 73 R&D projects (ibid: 29); 26 copyrights (ibid: 
29); researcher exchange program with CNRS, France (ibid: 73); 13 projects funded under 
INDIGO project of the European Research Area Network (ERA-NET) in India (ibid: 73); 
DBT-AIST Japan project among which one is bioinformatics (ibid: 74); Bioresources 
Database Development Programme - A digitized database of agro-plant has been launched 
using bioinformatics tools e.g “Inventory of Microbial Resources of India (MTCC)” (ibid: 
90); Indo-Canadian “collaborative programmes in genomics, bioinformatics and food 
processing, involving the exchange of faculty and scholars (ibid: 101); 
 
Seven new research institutions were established,  one is the National Institute of Biomedical 
Genomics (NIBMG) Kalyani. 
 
The 11th plan’s proposal to launch a single-window regulatory mechanism, the Biotechnology 
Regulatoy Authority of India (BRAI), for all biotech related approvals failed to materialize 
and is stated as one of the 12th plan objectives,  awaiting reintroduction to the parliament as a 
bill, but with modifications (PCi, 2013: 251) 
 
 
2012-2017 (Twelfth Five Year Plan 2012-2017)  
Target Growth: 8% (starting with 6% in 2011-12 and ending with 9% in the last 2 years) 
Actual Growth: % 
The 12th Plan is muted (almost) silent on the subject of bioinformatics. The word 
‘bioinformatics’ is only mentioned twice, both times referring to the proposed new research 
institution ‘Bioinformatics and Computational Biology.’ The word ‘informatics’ is mentioned 
4 times including the two references above, and twice as insignificant benefits of other 
projects. In the aftermath of the 2008 recession, the 12th plan appears to have moved away 
from the pursuing 11th plan’s ambitious goals in biotechnology and bioinformatics, at least 
on paper. Biotechnology no longer appears to be in the running as a vehicle for job creation 
or raising the standard of living. For instance, the 12th plan proposes e-governance, e-
security, e-learning etc but is not e-health. There are proposals to expand or launch 
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computerised databases of patient records etc at various levels, tele-medicine nodes, but little 
or no involvement with classical bioinformatics. Even the report on the 11th plan’s 
achievements never mentions the word informatics or bioinformatics (PCi, 2013: BOX 8.4: 
(pp 250)). The absence of bioinformatics is evident in the 3 statements below, 
 
 “For instance, biotechnology, which focuses on industrial enzymes, alternate energy, 
 seed manufacturing, diagnostics, vaccines, discovery research and clinical services 
 and biotech drugs, is emerging as an important focus area for the country” (PCi, 
 2013: Chapter 13.201 (pp 97)). 
 
 “13.148. Access to finance needs to be enlarged through alternative sources of 
 capital such as private equity, venture capital and angel funds. This is crucial for 
 facilitating the growth of knowledge-based enterprises which have high potential in 
 the Indian context. Further, prospective enterprises in emerging areas such as 
 nanotechnology, biotechnology, aerospace and defence applications would also 
 require such alternative sources of finance since traditional channels are unable to 
 meet their needs” (PCi, 2013: Chapter 13.148 (pp 86)).   
 
 “62.  Moving to a higher growth trajectory will require focussed institutional support 
 and incentivise the clusters to foster innovation, encouragement to maximise 
 investments in enhancing manufacturing capacities and aggressive drive for creation 
 of ‘Brand India’ image in select segments including biopharmaceuticals/biosimilars 
 and Indian systems of medicines” (PCi, 2013: 120). 
 
In stark contrast, the 2011 Report of the Working Group on Biotechnology (RWGoB, 2011; 
discussed later) under the DBT, contained a detailed report of gaps, challenges and 
recommendations for developing/expanding the bioinformatics sector – it was intended as a 
guiding report for the 12th plan’s biotech strategy. Similarly, both the National Biotechnology 
Development Strategy (NBDS; discussed later) in 2007 and 2014 contained detailed analyses 
of the bioinformatics sector with considerable page count devoted to the subject. 
Nevertheless, very little of that made it to the 12th plan document. It may very well be that a 
detailed discussion of the development of the bioinformatics sector was intended for the 
NBDS 2014 document and there was little need to address it in the plan document.  This 
could also imply a conscious effort to distance/separate bioinformatics sector from the 
‘inclusive growth’ goals of the 12th plan and allow it to pursue its ‘global leadership’ goals. 
Either way, the recommendations of the RWGoB (2011) were intentionally left out or the 
answer as to why that is requires further research.  
 
DST (12th plan Budget allocation Rs 21,596 crores) 
On the other hand, the DST goals for basic research are heartening for bioinformatics, albeit 
indirectly through the proposed support of basic research(ers). DST’s stated goal of 
increasing India’s basic research capacity is evident in its section heading “Scenario in Basic 
Research—Strategies for Global Positioning of India” and later “Strategic Interventions for 
India Emerging as One of the Top Six Global Powers in S&T Sector” (PCi, 2013: 246-247). 
This is in line with the 11th plan’s goals of India’s leadership in S&T. To catapult India from 
9th to 6th position globally in basic research, DST targets policies, 
-increasing the then 14% YOY growth of peer-reviewed publications to 62,500 per year. 
-increasing “R&D personnel” to 250,000. 
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One of the policies proposes increasing super-computing infrastructure but does not 
mention informatics or bioinformatics.  
 
DSIR (incl. CSIR) (12th plan Budget allocation Rs 17,896 crores) 
The Department of Scientific & Industrial Research (DSIR including CSIR) “promote 
industrial research, technology development and transfer to enable India to emerge as a 
global industrial research and innovation hub” (PCi, 2013: 261). Much like the DBT and 
DST, the phrase bioinformatics is conspicuously absent. Similar to the DBT and DST, 
proposals for new funding mechanisms, rejuvenation of existing institutions, PPP initiatives, 
international collaborative efforts, skilled human resource development initiatives, expansion 
of schemes supporting different stages and types of innovation, expansion of S&T research 
infrastructure including innovation clusters etc is expected to impact the bioinformatics 
sector along with others. Only under the heading “R&D in Clusters through National 
Laboratories”, the plan comes closest to targeting bioinformatics, 
 “Programmes of the National Laboratories in the Twelfth Five Year Plan would be 
 undertaken across five clusters which are as follows: Biological Science, Chemical 
 Science, Engineering Science, Information Science and Physical Science. There is a 
 specific focus on Human Resource Development in cluster mode. The projects have 
 been formulated to encompass intra-cluster, inter-cluster and trans-cluster entities 
 covering the domains of mega projects, large mission projects, supra-institutional 
 network projects…” (PCi, 2013: 261). 
 
 
 
Source: (PCi, 2013: 274(Annexure 8.1)). 
 
 
DBT (12th plan Budget allocation Rs 11,804 crores) 
 
The DBT’s goals for the 12th plan period are once again framed within developmental 
objectives for “inclusive growth” and the phrase ‘bioinformatics’ is never used, at least on 
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paper. However, under the heading “Rejuvenate existing and establish new research 
resources, facilities and services” “genomic and proteomic facilities; new generation 
sequencing service units” are mentioned (PCi, 2013: 251-252). A host of “innovative funding 
schemes” are proposed with the objective of supporting PPPs that are likely to indirectly 
impact bioinformatics,  
 “Ignition Grant Scheme available to individuals or a team of individuals–in 
 partnership with private investment agencies; schemes for creating and nurturing 
 start-up for early-stage technologies; provision of ‘bridge funding’ firms to function 
 between successive private equity funding or planning for IPOs; funding for 
 technology access and acquisition and licensing and special investment incentives to 
 industry for building more biotechnology/pharma special economic zones (SEZs). 
 Biotechnology Industry Research Assistance Council (BIRAC) would be made fully 
 operational in Twelfth Plan to assess and facilitate bio industry as per its mandate 
 and manage funding through PPP schemes. The affordable health technology 
 initiative with Wellcome Trust…” (PCi, 2013: 252). 
Under “Promoting new-generation biotech industries” the plan is silent on bioinformatics 
although “nano-bio industries” finds a mention (ibid). 
The only use of the phrase bioinformatics can be found under proposals for “New and 
autonomous research institutions” “…in emerging areas of translational research such as 
Bioinformatics and Computational Biology…” (PCi, 2013: Chapter 8.58.19(pp 253)).   
 
The BTISNet run by the DBT proposes the following (i.e. the following are not contained 
within the 12th plan document but under the BTISNet’s own vision document), 
  “Forth Coming Priority Areas (BTISNet, 2013), 
 - Establishment of Indian Institute of Bioinformatics (IIB)   
 - Establishment of Indian Data Centre in Biological Sciences   
 - Call for proposals for the development of software tools on analyzing NGS data   
 - Network project: Brainstorming on Identifying major network programs where the   
              Bioinformatics could play to enhance and speed up of the R&D.  
- Human Resource Development in Bioinformatics should be given emphasis.”  
 
RWGoB 2011:  
The Report of the Working Group on Biotech (RWGoB, 2011) recommended the following 
for DBT’s 12th plan objectives, but were ultimately left out of the 12th plan document (i.e. I 
could not find a mention), 
-Centre for DNA informatics and Computational Biology under CDFD.   
- A state of the art Crop Bioinformatics Centre  
 
A Comparison table of NBDS 2007 and NBDS 2014: 
National Biotechnology Development Strategy (NBDS), DBT, MST, GoI 
NBDS 2007 NBDS 2014 
Title: The Future Bioeconomy: Translating 
Life Sciences knowledge into socially 
relevant, eco friendly and competitive 
products 
None  
Note: Biotechnology regulation is stated as a 
“major challenge” in the first page. (page 3)  
Primary focus basic sciences, secondarily 
Translational/academia-industryspinoffs.(23)  
30% of budget earmarked for PPP  
Biotech Industry Partnership Prog (BIPP)   
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Expand Small Busi Innov Res Industry 
(SBIRI) – for SME’s 
 
Biotech Industry Res Asst Council (BIRAC) 
– for academia-industry collab in R&D 
 
Refocus uni & HR dev towards courses in 
genomics, proteomics, bioinformatics etc. 
“Build top-notch competence in 
technologies directly relevant to the growing  
bioeconomy  
-Existing technologies (e.g., genetic 
engineering, high throughput systems for 
DNA and RNA analysis, mass-spectrometry) 
-Emerging technologies (e.g., synthetic 
biology, systems biology, bioinformatics for  
data-intensive discovery, advanced 
proteomics, advanced imaging) 
-Effectively linked fundamental science with 
other sciences and technologies for novel  
bio-applications (e.g., nanoscience, material 
science, chemical biology, physical biology, 
ICT).  
Instruments for implementation: 
-New, multiuser, accessible Regional 
Advanced Technology Platforms with 
preferred university location, linked to 
incubators.  
-New centres on the lines of Centre for 
Cellular and Molecular Platforms (CCAMP), 
Bangalore for all bio clusters.  
-Advanced technology platforms linked to 
Inter-institutional Centres.” (page 5-6) 
UNESCO Regional Centre for Science, 
Education and Innovation in Biotech estb in 
Faridabad, Haryana health services cluster; 
focus on bioinformatics + 6 other areas. (8) 
The UNESCO center is estb. Proposal for 
“Establish 5 EMBL (European Molecular 
Biology Laboratories)-like centres in the 
country” (page 13). 
“New Breed of Institutions to be Set Up in 
Critical Areas” incl Medical genetics and 
Genomics as 1 of the 8 proposed. (page 8) 
NIBMG, Kalyani is up and running. 
Proposal to “incentivize establishment of 
Technology Development and Translational 
Cells in 50 research universities” (page 6) 
Agrifood cluster in Mohali, Punjab to incl 
Nanotechnology centre 
Estb Mohali cluster around 2010-2011; the 
nanotech institute is yet to be setup; the 
Bangalore cluster was already advanced. 
50+ CoEs incl centers for Bioinformatics 15 CoEs setup. 35 centres failed to pass min 
criteria – got support for programmes. 
Proposal to setup Centres of Excellence and 
Innovation (CoEI’s); DBT – partnered 
Centres of Excellence; Inter-institution 
centres; Virtual network centres. (page 15) 
“Beefing up” infrastructure to incl. gene 
banks (page 8) 
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 Under “new schemes to address gap areas” 
MSc program in Medical Bioinformatics is 1 
of 5. (page 13). 
 Vision 2025: under Translational genomics: 
focus on pharmacogenomics; “More 
widespread genomic testing services”; 
“epidemiology and genomics”; “genomics 
education”; “Institutional Mechanisms for 
Human Genome Research” (page 27-28).  
 
Under “Genomics and Genetic 
Characterization: Livestock and Poultry … 
using high density sequencing of genomic 
DNA/cDNA for SNP detection and 
development of SNP array. …Application of 
genome-wide marker-assisted selection 
(GWMAS) for enhancement of production, 
FCR and disease resistance. Page 41. Similar 
DNA marker technology in creating 
databases in marine biotech etc. page 44. 
 See immediately below for gaps and 
challenges in bioinformatics sector** 
 
** Under Human Resource development, the NBDS (2014: 59-60) identifies 8 different 
“gaps and challenges” in “(iii) Bioinformatics, Computational and Systems Biology” ranging 
from lack of people with expertise in bio & Informatics to lack of world-class teaching 
infrastructure etc. Then it continues to provide detailed recommendations to bridge the gaps 
such as attracting eminent Diaspora (INSPIRE) etc.  
However, the document undertakes a full sectoral analyses of “Bioinformatics, 
Computational and Systems Biology” as a separate section (pages 69-73).  The primary gaps 
and challenge of the sector are, 
“1) Lack of National data policy and a National data centre. Very few software tools & 
databases are developed in India. Most of those that exist are not validated and are highly 
fragmented. 
2) Lack of state-of-art computing facilities to analyze the voluminous data being generated 
and to carry out research at par with the world.” (NBDS, 2014: 69).  
Recommendations are provided along two strands- developing infrastructure and developing 
manpower. For the former, solutions range from establishing high quality research centres,  
creating a National data centre & policy that complement and strengthen the existing 
BTISNet e.g. “India must have its own data centre where the nationally generated database 
can be deposited,” expanding/setting-up world class supercomputing facilities etc. There is 
recognition of the challenges of low-levels of translational activity in the sector, especially in 
commercialisation. Likewise, policies targeting PPP, incentivizing academia-industry 
partnerships, setting up more incubators to attract industry are recommended as solutions. 
Additionally, some novel promissory areas where significant gaps exist on a global level are 
identified for future policy focus as below,  
“-Specialized tools for analyzing next generation sequencing data 
- Systems Biology in medical and plant sciences 
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- Biotherapeutics development 
- Computational tools for Synthetic Biology 
- Personalized medicine utilizing bioinformatics, systems biology and next generation 
genomics. 
- Development of data repositories for promoting translational bioinformatics 
- Molecular e-resources based on ‘omics’ platforms e.g. consolidation of small RNA data 
being developed by many labs across the country. 
- Health / Medical record e-resources  
- Plant trait e-resources 
- Clinical trial e-resources 
- Bio-safety data e-resources 
- Drug and drug target databases” (72-73). 
“International Cooperation” is identified as a major vehicle for meeting DBT’s goals 
including “Participation in Global Initiatives, …to provide a platform …for smooth global 
public-private partnerships, …strengthen its national biotech service sector such that India is 
the first global choice as a biotechnology service provider be it in the area of genomics, 
proteomics, data-mining etc., …Collaboration in higher education with the best in the, 
…organise international scientific meetings twice a year to debate and discuss Scientific 
Grand challenges” with the “Ultimate Goal: By 2025 DBT  international Cooperation 
should become robust enough such that foreign offices of DBT are required in USA, 
Europe etc., something like the BBSRC, DFID, Tekes offices.” (ibid) 
 
TABLE FOR 12TH PLAN OUTLAY  
Source: RWGoB, 2011: 239.  
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ANNEXURE 1 
 
    
 
 
 
 
 
 
 
 
 
 
                                                                    Source: Adapted from Department of Science and        
                                                                          Technology, Government of India. Available  
                                                                           online at < http://www.dst.gov.in/> 
 
Government of India – Department of Science & Technology 
 Yearly Outlay on Bioinformatics 
2005-2014 
Year Category of DST 
Budget Outlay 
E/A13 Millions 
of GBP 
Reference 
2005-
2006 
Bioinformatics A 1.66716 GoI-MST (2007-06) Government of India Detailed 
Demand for Grants of Ministry of Science & 
Technology for 2007-2008. Demand No. 83. 
                                                 
13 E represents estimated budget outlay. A represents actual spending.   
 Ministry of Science & Technology & Earth Sciences 
Dept. 
of 
Space 
Council of Scientific 
and Industrial 
Research (CSIR) 
 
Dept. of 
Science and 
Technology 
Dept. 
of Atomic 
Energy 
Dept. of Scientific 
and Industrial 
Research (DSIR) 
Dept. of 
Ocean 
Development 
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Department of Bio-Technology. Document 
776/S&T/2007-6. Page 37-45. Available online at 
< http://dbtindia.nic.in/docs/2007-08ddg.pdf> 
     
2006-
2007 
Bioinformatics E 
A 
2.2 
2.2973 
GoI-MST (2007-06) Government of India Detailed 
Demand for Grants of Ministry of Science & 
Technology for 2007-2008. Demand No. 83. 
Department of Bio-Technology. Document 
776/S&T/2007-6. Page 37-45. Available online at 
< http://dbtindia.nic.in/docs/2007-08ddg.pdf> 
     
2007-
2008 
Bioinformatics E 
A 
2.25 
2.055 
GoI-MST (2007-06) Government of India Detailed 
Demand for Grants of Ministry of Science & 
Technology for 2007-2008. Demand No. 83. 
Department of Bio-Technology. Document 
776/S&T/2007-6. Page 37-45. Available online at 
< http://dbtindia.nic.in/docs/2007-08ddg.pdf> 
     
2008-
2009 
Bioinformatics E 
A 
2 
2.17488 
GoI-MST (2007-08) Government of India Detailed 
Demand for Grants of Ministry of Science & 
Technology for 2008-2009. Demand No. 85. 
Department of Bio-Technology. Document 860 
S&T/08-5. Page 29-37. Available online at < 
http://dbtindia.nic.in/docs/2008-09ddg.pdf> 
     
2009-
2010 
Bioinformatics E 
A 
2 
1.2 
GoI-MST (2008-09) Government of India Detailed 
Demand for Grants of Ministry of Science & 
Technology for 2009-2010. Demand No. 85. 
Department of Bio-Technology. Document 2384 
S&T/09-5. Page 28-40. Available online at < 
http://dbtindia.nic.in/docs/2009-10ddg.pdf> 
     
2010-
2011 
Bioinformatics E 
A 
1.9 
2.2 
GoI-MST (2009-10) Government of India Detailed 
Demand for Grants of Ministry of Science & 
Technology for 2010-2011. Demand No. 86. 
Department of Bio-Technology. Document 656 Sc 
& Tech/2010-5. Page 27-39. Available online at < 
http://dbtindia.nic.in/docs/2010-11ddg.pdf> 
 
The figures for the actuals are in the ref. below, 
GoI-MST (2010-11) Government of India Detailed 
Demand for Grants of Ministry of Science & 
Technology for 2011-2012. Demand No. 87. 
Department of Bio-Technology. Document 729 
S&T/11-5A. Page 31-45. Available online at < 
http://dbtindia.nic.in/docs/2011-12ddg.pdf> 
     
2011- Bioinformatics E 1.9 GoI-MST (2011-12) Government of India Detailed 
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2012 (incl. new ‘Grant 
for creation of 
capital assets’ for 
Rs. 90m) 
A 1.9 Demand for Grants of Ministry of Science & 
Technology for 2012-2013. Demand No. 85. 
Department of Bio-Technology. Document 860 
S&T/08-5. Page 43-61. Available online at < 
http://dbtindia.nic.in/docs/2012-13ddg.pdf> 
     
2012-
2013 
Bioinformatics 
(incl. new ‘Grant 
for creation of 
capital assets’ for 
Rs. 60m) 
E 
A 
2.298 
2.038 
GoI-MST (2012-13) Government of India Detailed 
Demand for Grants of Ministry of Science & 
Technology for 2013-2014. Demand No. 85. 
Department of Bio-Technology. Document 860 
S&T/08-5. Page 46-66. Available online at < 
http://dbtindia.nic.in/docs/2013-14ddg.pdf> 
     
2013-
2014 
Bioinformatics 
(incl. new ‘Grant 
for creation of 
capital assets’ for 
Rs.57.7m) 
E 2.5 GoI-MST (2012-13) Government of India Detailed 
Demand for Grants of Ministry of Science & 
Technology for 2013-2014. Demand No. 85. 
Department of Bio-Technology. Document 860 
S&T/08-5. Page 46-66. Available online at < 
http://dbtindia.nic.in/docs/2013-14ddg.pdf> 
 
 
